financetom
Business
financetom
/
Business
/
SoundHound AI Insider Sold Shares Worth $2,379,916, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
SoundHound AI Insider Sold Shares Worth $2,379,916, According to a Recent SEC Filing
Jun 25, 2025 1:15 AM

03:49 AM EDT, 06/25/2025 (MT Newswires) -- Keyvan Mohajer, 10% Owner, Director, Chief Executive Officer, on June 20, 2025, sold 254,376 shares in SoundHound AI ( SOUN ) for $2,379,916. Following the Form 4 filing with the SEC, Mohajer has control over a total of 1,749,790 Class A common shares of the company, with 1,749,790 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1840856/000156218025005036/xslF345X05/primarydocument.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sagicor Financial Company Receives Ratings Upgrade from Fitch
Sagicor Financial Company Receives Ratings Upgrade from Fitch
Oct 21, 2025
05:20 PM EDT, 10/21/2025 (MT Newswires) -- Sagicor Financial ( SGCFF ) on Tuesday said global credit-rating agency Fitch Ratings upgraded its Long-Term Issuer Default Rating to BBB from BBB- and its senior unsecured debt rating to BBB- from BB+, while stating the outlook remains Stable. The company said Fitch cited Sagicor's strengthened core profitability, the second year of consolidated...
Alector's Latozinemab Fails in Phase 3 Dementia Trial; Workforce Cut by 49%; Shares Fall After Hours
Alector's Latozinemab Fails in Phase 3 Dementia Trial; Workforce Cut by 49%; Shares Fall After Hours
Oct 21, 2025
05:44 PM EDT, 10/21/2025 (MT Newswires) -- Alector ( ALEC ) said Tuesday that its Phase 3 trial of latozinemab in frontotemporal dementia caused by a progranulin gene mutation failed to meet its primary clinical endpoint. The company will halt the continuation study for latozinemab and reduce its workforce by 49%. Sara Kenkare-Mitra, president and head of research and development,...
National Bank Q3 Earnings, Revenue Rise
National Bank Q3 Earnings, Revenue Rise
Oct 21, 2025
05:44 PM EDT, 10/21/2025 (MT Newswires) -- National Bank ( NBHC ) reported adjusted Q3 earnings late Tuesday of $0.96 per diluted share, up from $0.86 a year earlier. Analysts polled by FactSet expected $0.85. Revenue, expressed as the sum of net interest income and total noninterest income, for the quarter ended Sep. 30 was $108.9 million, up from $106.0...
5PM Hourly update
5PM Hourly update
Oct 21, 2025
Please add/update the following to the Reuters Daybook for Wednesday, October 22: UPDATES WITH ROOM CHANGE SENATE ENVIRONMENT AND PUBLIC WORKS -- 10 a.m. -- Holds a hearing on the nominations of: Mitch Graves, Jeff Hagood, Randall Jones, and Arthur Graham to be members of the Board of Directors at the Tennessee Valley Authority ( TVC ) . The nominees...
Copyright 2023-2026 - www.financetom.com All Rights Reserved